In addition, ALO suppresses cell proliferation and invasion in human osteosarcoma cell lines, MG-63 and U2OS, by down-regulating the protein kinase B (Akt) signaling pathway (Chen et al., 2018). The gene discussed is AKT1; the disease is osteosarcoma.